WA
PBE icon

WBH Advisory’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

WBH Advisory’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,513
Closed -$213K – 299
2022
Q2 		$213K Hold
3,513
– – 0.03% 290
2022
Q1 		$203K Hold
3,513
– – 0.02% 307
2021
Q4 		$250K Hold
3,513
– – 0.03% 289
2021
Q3 		$263K Hold
3,513
– – 0.04% 257
2021
Q2 		$260K Hold
3,513
– – 0.04% 241
2021
Q1 		$259K Hold
3,513
– – 0.04% 239
2020
Q4 		$271K Sell
3,513
-100
-3% -$6.33K 0.05% 227
2020
Q3 		$205K Hold
3,613
– – 0.04% 239
2020
Q2 		$210K Buy
+3,613
New +$197K 0.05% 226
2020
Q1 		– Sell
-3,762
Closed -$210K – 235
2019
Q4 		$210K Buy
+3,762
New +$196K 0.04% 231
2019
Q3 		– Sell
-3,762
Closed -$201K – 239
2019
Q2 		$201K Hold
3,762
– – 0.05% 227
2019
Q1 		$207K Buy
+3,762
New +$199K 0.05% 225
2018
Q4 		– Sell
-3,963
Closed -$235K – 237
2018
Q3 		$235K Buy
3,963
+1
+0% +$58 0.06% 228
2018
Q2 		$216K Buy
+3,962
New +$201K 0.06% 222
2016
Q1 		– Sell
-4,958
Closed -$250 – 203
2015
Q4 		$250 Buy
4,958
+2
+0% +$99 0.09% 166
2015
Q3 		$226K Buy
4,956
+1
+0% +$56 0.09% 174
2015
Q2 		$289K Buy
4,955
+1
+0% +$57 0.11% 160
2015
Q1 		$273 Sell
4,954
-100
-2% -$5.41K 0.08% 171
2014
Q4 		$253K Buy
+5,054
New +$247K 0.1% 174
2014
Q3 		– Sell
-5,154
Closed -$225K – 215
2014
Q2 		$225K Buy
5,154
+3
+0.1% +$122 0.09% 195
2014
Q1 		$214K Buy
+5,151
New +$220K 0.09% 198

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CW
CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $938M AUM 29.36% 1-Year Est. Return

WBH Advisory's PBE Position: Q3 2022 in Review

WBH Advisory sold out of Invesco Biotechnology & Genome ETF (PBE) in Q3 2022, closing a stake of 3,513 shares — an estimated $213K sold.

WBH Advisory first reported a position in PBE in Q1 2014 and held it in 21 quarters. The position peaked at $289K in Q2 2015. 86 funds tracked by Wall St. Rank hold PBE as of Q3 2022.

  • WBH Advisory reported no remaining Invesco Biotechnology & Genome ETF position as of Q3 2022 after selling out during the quarter.
  • WBH Advisory sold 3,513 Invesco Biotechnology & Genome ETF shares in Q3 2022, an estimated $213K.
  • WBH Advisory first reported a position in Invesco Biotechnology & Genome ETF in Q1 2014 and held it in 21 quarters.
  • WBH Advisory's Invesco Biotechnology & Genome ETF position peaked at $289K in Q2 2015.
  • 86 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2022.

Based on WBH Advisory's 13F filing for Q3 2022, filed 18 Oct 2022.